Chintagumpala M M, Kennedy L L, Steuber C P
Department of Pediatrics, Texas Children's Cancer Center, Houston 77030, USA.
J Pediatr. 1995 Sep;127(3):495-8. doi: 10.1016/s0022-3476(95)70090-0.
Essential thrombocythemia (ET) is a myeloproliferative disorder characterized by persistent elevation in platelet count. It is a rare disorder in children, and children who have symptoms require treatment. We report the successful use of anagrelide, with few toxic effects, in the treatment of three children with ET.
